BRAF and melanoma: A search for mutations in the mitogen-activated protein (MAP) kinase pathway in various common cancers by Davies et al, revealed that 40% to 60% of melanomas, and a 7 to 8% of all cancers carry an activating mutation in the gene encoding the serine-threonine protein kinase BRAF (Figure 2)[29,30].